When was Precision Neuroscience founded?

Precision Neuroscience was founded in 2021 and raised its 1st funding round within a year of its incorporation.

Where is Precision Neuroscience located?

Precision Neuroscience is headquartered in New York City, United States. It is registered at 5900 BALCONES DR STE 100,AUSTIN,TX,78731.0,227.

Which legal entities is Precision Neuroscience associated with?

Precision Neuroscience is associated with Precision Neuroscience Corporation.

How many employees does Precision Neuroscience have?

As of Jul 31, 2026, the latest employee count at Precision Neuroscience is 130.

Is Precision Neuroscience a funded company?

Precision Neuroscience is a funded company, having raised a total of $183M across 6 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Apr 27, 2021.

How much is Precision Neuroscience worth?

The latest valuation of Precision Neuroscience is $***** as of Oct 02, 2024.

When was the latest funding round of Precision Neuroscience?

Precision Neuroscience's latest funding was a $***** Series C round on Nov 05, 2025, with participation from 1 investor.

Where does Precision Neuroscience rank among its competitors?

Precision Neuroscience ranks 1st amongst 102 active competitors, of which 21 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was LIFESCAPES, which secured $3.74M in Jun, 2026.

Who are the top competitors of Precision Neuroscience?

Precision Neuroscience's top competitors include Blackrock Neurotech, Nexstim and g.tec. Among them, LIFESCAPES secured the most recent funding round in June, 2026.

Precision Neuroscience - 2026 Company Profile, Team, Funding & Competitors

Precision Neuroscience is a series C company based in New York City (United States), founded in 2021 by Benjamin Rapoport. It operates as a Developed of brain-computer interface tool for medical treatment and drug development. Precision Neuroscience has raised $183M in funding from investors like Steadview, General Equity Holdings and SCI Ventures, with a current valuation of $*****. The company has 102 active competitors, including 21 funded and 12 that have exited. Its top competitors include companies like Blackrock Neurotech, Nexstim and g.tec.

Company Details

Developed of brain-computer interface tool for medical treatment and drug development. The company has developed a next-generation brain computing technology that has the ability to process medicine and computing. The brain implants have features for AI-based computing, device integration, and assessment of neurological illness for medicine development.

Website: www.precisionneuro.io/
Registered Address: 5900 BALCONES DR STE 100,AUSTIN,TX,78731.0,227

Key Metrics

Founded Year

2021

Location

New York City, United States

Stage

Series C

Total Funding

$183M in 6 rounds

Latest Funding Round

Series C, Nov 05, 2025, $*****

Post Money Valuation

$***** as on Oct 02, 2024

Investors

Steadview & 11 more

Ranked

1^st among 102 active competitors

Employee Count

130 as on Jul 31, 2026

Similar Companies

Blackrock Neurotech & 117 more

View Precision Neuroscience's full profile

Precision Neuroscience is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Precision Neuroscience Corporation CIN: 32091713340 , United States, Active	Sep 19, 2023	-	-	-

Precision Neuroscience has raised a total funding of $183M over 6 rounds. Its first funding round was on Apr 27, 2021. Its latest funding round was a Series C round on Nov 05, 2025 for $*****. 1 investor participated in its latest round. Precision Neuroscience has 12 institutional investors.

Here is the list of recent funding rounds of Precision Neuroscience:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 05, 2025	2331728	Series C	3786620	6547954	9488312	6854611
Jan 28, 2025	9669863	Series C	1172561	9743619	8647591	Jdpglobal
Oct 02, 2024	7463189	Series C	4251386	8778504	General Equity Holdings	B Capital & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Precision Neuroscience's funding rounds and investors

The founders of Precision Neuroscience is Benjamin Rapoport.

Here are the details of Precision Neuroscience's key team members:

Benjamin Rapoport: Co-Founder & CSO of Precision Neuroscience.

View details of Precision Neuroscience's Founder profiles and Board Members

Precision Neuroscience's employee count trend

Precision Neuroscience has 130 employees as of Jul 26. Here is Precision Neuroscience's employee count trend over the years:

Employee count trend for Precision Neuroscience

Uncover Precision Neuroscience's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Precision Neuroscience include Blackrock Neurotech, Nexstim and g.tec. Here is the list of Top 10 competitors of Precision Neuroscience, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Precision Neuroscience 2021, New York City (United States), Series C	Developed of brain-computer interface tool for medical treatment and drug development	$183M	Steadview, Mubadala & 10 others	65/100
2nd	Blackrock Neurotech 2008, Salt Lake City (United States), Acquired	Developer of medical devices for neurological therapies	$22.4M	re.Mind Capital, Cavendish Privateers & 12 others	62/100
3rd	Nexstim 2000, Helsinki (Finland), Public	Provider of noninvasive brain stimulation for rehabilitating stroke patients	$29.7M	Kreos Capital, Lundbeck Foundation & 8 others	52/100
4th	g.tec 1999, Schiedlberg (Austria), Funding Raised	Provider of high-performance brain-computer interfaces and neurotechnologies for invasive and non-invasive recordings	-	EIC Fund, Europa	51/100
5th	Helius Medical 2014, Newtown Square (United States), Public	Developer of neurological rehabilitation medical devices	$391K	Summer Capital Management Company, Pantera Capital ... & 14 others	51/100
6th	LIFESCAPES 2018, Minato City (Japan), Series A	Developer of brain-machine interface devices for neurorehabilitation	$3.74M	Beyond Next Ventures, Shionogi & 9 others	50/100
7th	Synergia Medical 2013, Mont Saint Guibert (Belgium), Series B	Developer of an active implantable neurostimulator and contact-less patient monitoring system	$14.2M	Newton Biocapital, SFPI & 8 others	47/100
8th	Minnetronix Medical 1996, Saint Paul (United States), Acquired	Manufacturer of multiple devices for neurocritical patients	$20M	Altaris, NIH & 1 others	46/100
9th	Endonovo Therapeutics 2011, Los Angeles (United States), Public	Bioelectronic devices and therapies for regenerative medicine	-	Kodiak Capital, Azure Capital Partners & 2 others	46/100
10th	BIONIK 2010, Toronto (Canada), Public	Provider of assistive and rehabilitation hardware and software solutions	-	Ginger Capital, MBX Capital & 3 others	45/100